Dyson has announced that it will develop a new type of breathing apparatus to the National Health Service NHS to help fight the Corona virus.
A Dyson spokesperson said: "Dyson has responded to the Government's request for support with its Covid-19 response by focusing resources into the design and manufacture of a ventilator for the NHS".
"It will be upscaling, on more of an industrial scale, existing ventilator designs", one of the sources said.
However, some industry critics have suggested that Dyson's process of designing a new model will take too long.
Dyson said for the project: "It is a very complicated task that has been undertaken in an extremely hard time frame".
"We are conducting a fully regulated medical device development, including testing in the laboratory and in humans, and we are scaling up for volume". Engineers, anesthesiologists and surgeons from Oxford University and King's College London are working on a new type of breathing apparatus.
Their model is less advanced than existing commercial models, but is quicker to construct, according to the BBC.
"Creating new designs which can complement existing models might help meet demand", commented Dr Federico Formenti, who is part of the OxVent team. "For example, you can not put a Formula 1 component in a breathing apparatus." said.
The project is still waiting to hear back from the government. It normally takes two to three years to design and launch a new breathing apparatus. Of these 5,000, 80pc will be sent to other countries in need of them.
With global demand for ventilators as the pandemic spreads, ventilators have been one of the most sought after products in the world.
"Great products come from painstaking testing, refinement and a deep understanding of the context of use", he added.
"This new device can be manufactured quickly, efficiently and at volume".
The company's product chief previously warned that asking non-specialists to make ventilators would be "unrealistic".
"We are doing everything possible to substantially increase production of our ventilators at our Luton site and worldwide", said Andrew Reynolds Smith, chief executive of Smiths.